Table 1.
Characteristics of the patients included in the study (N = 842).
| Characteristics | N (%) |
|---|---|
| Age (years)# | 60.5 ± 10.9 |
| Gender | |
| Male | 629 (74.7) |
| Female | 213 (25.3) |
| Depth of invasion | |
| T1 | 94 (11.1) |
| T2 | 104 (12.4) |
| T3 | 524 (62.2) |
| T4 | 120 (14.3) |
| Lymph node metastasis | |
| N0 | 234 (27.8) |
| N1 | 219 (26.0) |
| N2 | 180 (21.4) |
| N3 | 209 (24.8) |
| TNM stage | |
| I | 134 (15.9) |
| II | 318 (37.8) |
| III | 390 (46.3) |
| Histological grading | |
| Poorly differentiated | 586 (69.6) |
| Well or moderately differentiated | 256 (30.4) |
| Vascular invasion | |
| Positive | 617 (73.3) |
| Negative | 225 (26.7) |
| Neural invasion | |
| Positive | 465 (55.2) |
| Negative | 377 (44.8) |
| Pathological type | |
| Tubular adenocarcinoma | 719 (85.4) |
| Signet-ring cell carcinoma | 75 (8.9) |
| Other types | 48 (5.7) |
| Chemotherapy | |
| No | 584 (69.4) |
| Yes | 258 (30.6) |
| Fibrinogen (g/L)∗ | 3.11 (1.14-10.91) |
| Albumin (g/L)∗ | 37.2 (4.6-50.5) |
| Fib-Alb score | |
| 0 | 376 (44.7) |
| 1 | 327 (38.8) |
| 2 | 139 (16.5) |
#Mean ± sd; ∗median (range).